Surgeries & Interventions

Contrast Use During PCI on the Decline

New ACC registry data suggests interventional cardiologists are using less contrast for PCI procedures in the cath lab which helps reduce post-PCI acute kidney injury risks, but a deeper look tells us there’s still room for improvement.

  • Iodinated contrast agents are commonly used for PCI with gadolinium-based contrast serving as an alternative but both can cause complications like acute kidney injury.
  • However, the trend is shifting towards minimizing or avoiding contrast use, especially in high-risk patients, through techniques like “zero-contrast” or “ultra-low contrast” PCI.

Searching for cath lab trends, researchers examined 3.12M unique PCI procedures performed by 3.6k physicians from 2018 to 2022 and found that the average contrast volume used during PCI decreased modestly but consistently over the study’s four years.

  • Overall mean PCI contrasts volumes decreased from 168.1 mL in 2018 to 149.8 mL by 2022.
  • Encouragingly, patients at higher preprocedural AKI risk also consistently received less contrast than those at lower risk (160.5 mL vs. 171.3 mL in 2018 down to 143.4 mL vs. 150.4 mL in 2022). 

While the trend is in the right direction, researchers still highlighted that there’s plenty of room for improvement across the board.

  • For example, 37.5% of physicians did not significantly decrease their contrast use during the four years they were followed, while 20% didn’t change volumes at all.
  • When categorized by percent change, 77.1% did not significantly change the amount of contrast they used per procedure.
  • Meanwhile, 1.9% of physicians actually increased their average contrast by >20%.

So what’s the answer? One recent RCT in Canada implemented preprocedural guidelines for safe contrast amounts and showed decreases in both contrast volume and AKI, particularly in higher-risk patients.

  • However, the trial provided feedback at the individual operator level rather than at the site level, so it’s unknown if site-level feedback alone can reduce AKI rates.

The Takeaway

PCI contrast use is headed in the right direction, but there’s still work to be done when it comes to messaging and convincing physicians about reducing volumes during procedures. Whether that’s achieved by more research, a better contrast alternative, or stronger education remains to be seen.

Get twice-weekly insights on the biggest stories shaping cardiology.

You might also like

Cardiac Imaging June 16, 2025

Beyond Hardware: Is AI the Answer to Making Cardiac Imaging more Accessible? June 16, 2025

Sponsored by Philips Healthcare Cardiac imaging has traditionally improved through hardware advances, enabling the speed needed for high-quality images. However, hardware is rapidly reaching its physical limitations in suppressing cardiac motion and represents a large financial investment. Today, software and AI are driving the next leap in cardiac image quality and motion control – offering […]

Cardiology Pharmaceuticals June 12, 2025

FDA Approves a New BP Triple Polypill June 12, 2025

Bringing a more effective BP therapy to the U.S. market, the FDA approved George Medicines’ triple therapy polypill called Widaplik for patients with hypertension, making it the first of its kind to go to market in the U.S. Widaplik’s approval stems from two studies, including one comparing the polypill against placebo as an initial treatment […]

Cardiology Pharmaceuticals June 12, 2025

Pharmacologic Preconditioning to Improve Outcomes in Patients Undergoing Cardiac Surgery  June 12, 2025

The majority of patients undergoing cardiac surgery, especially those on cardiopulmonary bypass (CPB), experience post-operative complications such as new-onset atrial fibrillation (POAF) and acute kidney injury (AKI), largely driven by oxidative stress and inflammation.   Several approaches have been explored to reduce complications following cardiac surgery, however, a clinically meaningful impact has yet to be realized.  […]

You might also like..

Select All

You're signed up!

It's great to have you as a reader. Check your inbox for a welcome email.

-- The Cardiac Wire Team

You're all set!